- Project description:
-
By combining statistical and network modeling and systems analysis with basic research and clinical data we aim to elucidate mechanisms of therapy-resistance of melanoma and to identify combinatorial systems biomarkers to prognosticate treatment responsiveness of BRAF mutated metastatic melanoma to BRAF (dabrafenib) / MEK (trametenib) inhibitors and to TRAIL death receptor agonists.
Project coordination
![This image shows Roland Kontermann](https://www.izi.uni-stuttgart.de/institut/team/verzeichnis/img/Kontermann.png?__scale=w:150,h:150,cx:0,cy:52,cw:2000,ch:2000)
Roland Kontermann
Prof. Dr.Deputy Head of the Institute (Biomedical Engineering)